Literature DB >> 2989501

Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction.

K G Lurie, G Tsujimoto, B B Hoffman.   

Abstract

Desensitization of alpha-1 receptor-mediated smooth muscle contraction was studied in rabbit aorta. Incubation of rabbit aorta ring segments with epinephrine (10(-6) M) for 7 hr resulted in a 10-fold loss in sensitivity of the tissue to alpha-1 adrenergic receptor-mediated contraction with no change in maximal force of contraction. This loss in sensitivity was specific for alpha-1 receptor-mediated contraction because responses to histamine and serotonin were unchanged in these aortas. Conversely, prolonged exposure of vessels to histamine (10(-5) M) led to desensitization of histamine-mediated contraction without altering responses to alpha-1 receptor stimulation. Using [125I] BE2254, a potent alpha-1 receptor antagonist, the loss in sensitivity to catecholamines was found not to be mediated by down-regulation of alpha-1 receptors nor by a loss in their affinity for epinephrine. However, desensitization was associated with a blunting of alpha-1 receptor stimulation of phosphatidylinositol turnover. These results suggest that desensitization of alpha-1 receptor-mediated contraction in rabbit aorta does not appear to be mediated by changes in receptor number or affinity but may involve alterations in receptor coupling.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989501

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  The role of nitric oxide synthase in reduced vasocontractile responsiveness induced by prolonged alpha1-adrenergic receptor stimulation in rat thoracic aorta.

Authors:  Hakan Gürdal; Alp Can; Mehmet Uğur
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  Impaired feedback regulation of the receptor activity and the myofilament Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Katsuharu Kameda; Mayumi Hirano; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

3.  Norepinephrine-induced alteration in the coupling of alpha 1-adrenergic receptor occupancy to calcium efflux in rabbit aortic smooth muscle cells.

Authors:  W S Colucci; R W Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system.

Authors:  G Tsujimoto; K Hashimoto; B B Hoffman
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

5.  Repeated local administration of noradrenaline or saline inhibits thermal hyperalgesia in pain-sensitized human skin.

Authors:  P D Drummond; D M Lipnicki
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

6.  Role of β3-adrenoceptors in regulation of retinal vascular tone in rats.

Authors:  Asami Mori; Tsutomu Nakahara; Kenji Sakamoto; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-08       Impact factor: 3.000

7.  In vivo desensitization of glycogenolysis to Ca2+-mobilizing hormones in rat liver cells.

Authors:  G Tsujimoto; A Tsujimoto; K Kato; K Hashimoto
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Desensitization of histamine H1 receptor-mediated inositol phosphate accumulation in guinea pig cerebral cortex slices.

Authors:  D R Bristow; P C Banford; I Bajusz; A Vedat; J M Young
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Agonist-induced desensitization of histamine H1 receptor-mediated inositol phospholipid hydrolysis in human umbilical vein endothelial cells.

Authors:  G McCreath; I P Hall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Altered neurotransmitter control of reflex vasoconstriction in aged human skin.

Authors:  Caitlin S Thompson; W Larry Kenney
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.